First Citizens BancShares Inc. (FCNCA) Forms $373.95 Double Top, Glenhill Advisors Lowered Allscripts Healthcare Solutn (MDRX) Position

July 17, 2017 - By Ellis Scott

First Citizens BancShares Inc. (FCNCA) formed double top with $392.65 target or 5.00% above today’s $373.95 share price. First Citizens BancShares Inc. (FCNCA) has $4.71 billion valuation. About 2,966 shares traded. First Citizens BancShares Inc. (NASDAQ:FCNCA) has risen 33.93% since July 17, 2016 and is uptrending. It has outperformed by 17.23% the S&P500.

Glenhill Advisors Llc decreased Allscripts Healthcare Solutn (MDRX) stake by 26.38% reported in 2016Q4 SEC filing. Glenhill Advisors Llc sold 2.74M shares as Allscripts Healthcare Solutn (MDRX)’s stock declined 3.95%. The Glenhill Advisors Llc holds 7.66 million shares with $78.21 million value, down from 10.40M last quarter. Allscripts Healthcare Solutn now has $2.23 billion valuation. The stock declined 0.33% or $0.04 reaching $12.17 per share. About 171,990 shares traded. Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) has declined 8.32% since July 17, 2016 and is downtrending. It has underperformed by 25.02% the S&P500.

Investors sentiment increased to 1.09 in Q4 2016. Its up 0.10, from 0.99 in 2016Q3. It increased, as 32 investors sold MDRX shares while 73 reduced holdings. 38 funds opened positions while 76 raised stakes. 178.73 million shares or 5.65% less from 189.44 million shares in 2016Q3 were reported. Illinois-based Archford Cap Strategies Limited has invested 0% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Bluemountain Mgmt Llc has invested 0% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). First Eagle Mngmt Ltd accumulated 0.11% or 4.11 million shares. 15,750 were reported by Manatuck Hill Llc. Allianz Asset Ag accumulated 765,428 shares or 0.01% of the stock. Kanaly Tru has 262 shares for 0% of their portfolio. Millennium Mngmt Lc holds 0% of its portfolio in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) for 17,262 shares. Boston holds 0.06% or 4.15M shares in its portfolio. Patten And Patten Tn invested 0.05% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Paradigm Mngmt New York reported 1.99 million shares stake. Citadel Advisors Limited Liability Corp reported 0% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Tributary Mgmt Limited Liability Corp has invested 0.13% in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Riverhead Mngmt Ltd Llc holds 0.01% of its portfolio in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) for 8,500 shares. Moreover, Teachers Retirement Of The State Of Kentucky has 0.01% invested in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX). Axa reported 429,600 shares.

Since March 23, 2017, it had 0 buys, and 2 insider sales for $475,850 activity. $174,467 worth of stock was sold by Farley Brian on Thursday, March 23. Another trade for 25,000 shares valued at $301,383 was sold by Poulton Richard J..

Analysts await Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) to report earnings on August, 3 after the close. They expect $0.12 earnings per share, up 20.00% or $0.02 from last year’s $0.1 per share. MDRX’s profit will be $21.99 million for 25.35 P/E if the $0.12 EPS becomes a reality. After $0.10 actual earnings per share reported by Allscripts Healthcare Solutions Inc for the previous quarter, Wall Street now forecasts 20.00% EPS growth.

Among 22 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Allscripts-Misys Healthcare had 35 analyst reports since August 5, 2015 according to SRatingsIntel. As per Friday, February 19, the company rating was maintained by RBC Capital Markets. Maxim Group maintained it with “Buy” rating and $16 target in Tuesday, January 10 report. The rating was maintained by Robert W. Baird on Tuesday, June 6 with “Buy”. The rating was reinitiated by JP Morgan on Friday, October 28 with “Overweight”. The rating was reinitiated by Jefferies on Friday, October 16 with “Buy”. RBC Capital Markets maintained it with “Sector Perform” rating and $14 target in Wednesday, August 5 report. The rating was upgraded by Morgan Stanley to “Overweight” on Wednesday, March 30. The stock of Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) earned “Outperform” rating by RBC Capital Markets on Thursday, January 7. The firm has “Market Perform” rating by Leerink Swann given on Monday, June 19. JP Morgan initiated the stock with “Overweight” rating in Tuesday, November 17 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: